Medical News

Wake Forest Baptist Medical Center Launches Precision Medicine Program

In an effort to personalize medicine, Wake Forest Baptist Medical Center announced a new Precision Medicine program at its cancer center. Precision medicine, introduced to the nation during President Barack Obama’s State of the Union address, uses a person’s unique genetic makeup to develop an individualized treatment plan. For cancer, …

Read More »

FDA Approves Genentech’s Lucentis for Treatment of Diabetic Retinopathy

Genentech’s Lucentis (ranibizumab injection) received expanded US approval for treatment of diabetic retinopathy (DR) in patients with diabetic macular edema (DME). The company announced that the drug received its fourth indication approved by the US Food and Drug Administration (FDA). The agency approved Lucentis 0.3 mg to be used along …

Read More »

Alkermes’ Reformulated Tecfidera Shows Fewer Side Effects in Early-Stage Study

Dublin-based Alkermes plc announced positive results from an early-stage stage study, evaluating its novel monomethyl fumarate (MMF) molecule in development for the treatment of multiple sclerosis (MS). The company announced positive topline results from a Phase I study of ALKS 8700, the company’s reformulated version of Biogen Idec’s blockbuster MS …

Read More »

Achillion’s Investigational Regimen Clears Hepatitis C in Six Weeks

  Today, Achillion Pharmaceuticals, Inc. announced new trial results, which demonstrated that its experimental hepatitis C drug, when used in combination with Gilead Sciences Inc’s Sovaldi, eliminated the virus after just six weeks of therapy. The company provided an update on interim results from the ongoing interferon-free, ribavirin-free, Phase II …

Read More »

Northwestern Onco-SET Launched to Provide Precision Medicine to Cancer Patients

The Robert H. Lurie Comprehensive Cancer Center of Northwestern University, in collaboration with Northwestern Medicine Developmental Therapeutics Institute (NMDTI) and Northwestern Memorial Hospital, has launched a new research program aimed at providing precision medicine to cancer patients. The companies announced the launch of Northwestern Onco-SET (Sequence, Evaluate, Treat) to provide …

Read More »

Pfizer’s Breast Cancer Drug Receives Accelerated Approval from the FDA

Federal health regulators have provided an early approval to Pfizer Inc.’s Breakthrough breast cancer drug palbociclib. The company announced that the US Food and Drug Administration (FDA) has granted accelerated approval of Ibrance (palbociclib) in combination with letrozole, for the treatment of postmenopausal women with estrogen receptor-positive, human epidermal growth …

Read More »

Physician’s Offices and Clinics Remain Largest Customer Base for Specialty Rx Distributors

Center Research Highlights Latest Trends for Fast-Growing Specialty Market Segment ARLINGTON, Va., February 3, 2015 — Physician’s offices and independently owned and operated physician clinics remain the largest customer base for specialty pharmaceutical distributors, at 63 percent of their sales value, according to the2014 Specialty Pharmaceutical Distribution: Facts, Figures and …

Read More »

White House Provides Details for Obama’s $215 Million Precision Medicine Initiative

Following up on President Barack Obama’s announcement in his State of the Union Address, the Administration unveiled details about the Precision Medicine Initiative, including plans to collect genetic data on one million Americans. On Friday, Obama gave more details about the initiative that he originally announced during his State of …

Read More »

Quest Diagnostics and CDC Partner to Improve Hepatitis Diagnosis and Treatment

Quest Diagnostics is collaborating with the Centers for Disease Control and Prevention (CDC) to identify trends in screening, diagnosis and treatment of four strains of viral hepatitis in the US. Quest Diagnostics will provide CDC researchers with analytics and access to its national database of de-identified clinical testing hepatitis data. …

Read More »

Scientists Use Modified RNA for Telomere Extension

Scientists discovered a new procedure that can quickly and efficiently increase the length of human telomeres, which could help in a range of diseases, including Duchenne muscular dystrophy (DMD) to diabetes. Researchers from the Stanford University School of Medicine used modified messenger RNA to extend telomeres, the protective caps on …

Read More »